Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19

Authors: Alexandra C. Apple,Alexis Oddi,Michael J. Peluso,Breton M. Asken,Timothy J. Henrich,J. Daniel Kelly,Samuel J. Pleasure,Steven G. Deeks,Isabel Elaine Allen,Jeffrey N. Martin … See all authors  Annals of Clinical and Translational NeurologyVolume 9,…[...]

Read More

Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortality

Authors: Ruturaj R. Masvekar,Peter Kosa,Kimberly Jin,Kerry Dobbs,Michael A. Stack,Riccardo Castagnoli,Virginia Quaresima,Helen C. Su,Luisa Imberti,Luigi D. Notarangelo,Bibiana Bielekova 21 March 2022 Annals of Clinical and Translational Neurology Volume 9, Issue 5 p.…[...]

Read More

Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2

Authors: Karolina Kania,Wojciech Ambrosius,Elzbieta Tokarz Kupczyk,Wojciech Kozubski 04 September 2021 Annals of Clinical and Translational NeurologyVolume 8, Issue 10 p. 2000-2003 Abstract Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and…[...]

Read More

Most long-COVID sufferers battle neurological symptoms, including some cognitive issues never seen before

Authors: Jocelyn Solis-Moreira JUNE 20, 2022 https://www.braintomorrow.com/ People continue to experience neurological problems six months after recovering from a COVID-19 infection, finds a recent study from the University of California…[...]

Read More

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573.  Apr 27.  2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory…[...]

Read More